Genetic susceptibility to systemic lupus erythematosus

被引:243
作者
Vyse, TJ [1 ]
Kotzin, BL [1 ]
机构
[1] Natl Jewish Med & Res Ctr, Div Basic Sci, Denver, CO 80206 USA
关键词
autoimmune disease; autoantibodies; genetic linkage; gene mapping; murine lupus;
D O I
10.1146/annurev.immunol.16.1.261
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Considerable evidence suggests that the development of systemic lupus erythematosus (SLE) has a strong genetic basis. Recent studies have emphasized that this disease, like other autoimmune diseases, is a complex genetic trait with contributions from major histocompatibility complex (MHC) genes and multiple non-MHC genes. Etiologic genes in these disorders determine susceptibility, and no particular gene is necessary or sufficient for disease expression. Studies of murine models of lupus have provided important insight into the immunopathogenesis of IgG autoantibody production and lupus nephritis, and genetic analyses of these mice overcome certain obstacles encountered when studying patients. Genome-wide linkage studies of different crosses have mapped the position of at least 12 non-MHC disease-susceptibility loci in the New Zealand hybrid model of lupus. Although the identity of the actual genes is currently unknown, recent studies have begun to characterize how these genetic contributions may function in the autoimmune process, especially in terms of their role in autoantibody production. Studies of MHC gene contributions in New Zealand mice have shown that heterozygosity for particular haplotypes greatly increases pathogenic autoantibody production and the incidence of severe nephritis. The mechanism for this effect appears to be genetically complex. Studies in human SLE have mostly focused on the association of disease with alleles of immunologically relevant genes, especially in the MHC. Associations with various complement component deficiencies and an allele of a particular Fc gamma receptor gene (FCGR2A) also have been described. In a diversion from previous association studies, a recent directed linkage analysis of sibpairs with SLE was based on mapping studies in murine lupus and may be an important step toward identifying a new disease-susceptibility gene in patients. Since the genes that predispose to autoimmunity are probably related to key events in pathogenesis, their identification in patients and murine models will almost certainly provide important insight into the breakdown of immunological self-tolerance and the cause of autoimmune disease.
引用
收藏
页码:261 / 292
页数:32
相关论文
共 139 条
  • [1] Die and let live: Eliminating dangerous lymphocytes
    Abbas, AK
    [J]. CELL, 1996, 84 (05) : 655 - 657
  • [2] TREATMENT OF (NZBXNZW)F1 DISEASE WITH ANTI-I-A MONOCLONAL-ANTIBODIES
    ADELMAN, NE
    WATLING, DL
    MCDEVITT, HO
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) : 1350 - 1355
  • [3] GENETIC-ASPECTS OF HUMAN LUPUS
    ARNETT, FC
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (01): : 4 - 6
  • [4] MOLECULAR ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLELES ASSOCIATED WITH THE LUPUS ANTICOAGULANT
    ARNETT, FC
    OLSEN, ML
    ANDERSON, KL
    REVEILLE, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) : 1490 - 1495
  • [5] ATKINSON JP, 1992, SYSTEMIC LUPUS ERYTH, P87
  • [6] SEROLOGIC SUBSETS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - AN EXAMINATION OF AUTOANTIBODIES IN RELATIONSHIP TO CLINICAL-FEATURES OF DISEASE AND HLA ANTIGENS
    BELL, DA
    MADDISON, PJ
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (11): : 1268 - 1273
  • [7] Multiple loci for multiple sclerosis
    Bell, JI
    Lathrop, GM
    [J]. NATURE GENETICS, 1996, 13 (04) : 377 - 378
  • [8] MHC-LINKED PROTECTION FROM DIABETES DISSOCIATED FROM CLONAL DELETION OF T-CELLS
    BOHME, J
    SCHUHBAUR, B
    KANAGAWA, O
    BENOIST, C
    MATHIS, D
    [J]. SCIENCE, 1990, 249 (4966) : 293 - 295
  • [9] Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease
    Bottto, M
    Theodoridis, E
    Thompson, EM
    Beynon, HLC
    Briggs, D
    Isenberg, DA
    Walport, MJ
    Davies, KA
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) : 264 - 268
  • [10] BOWNESS P, 1994, Q J MED, V87, P455